OsteoGeneX is developing a first in class bone building small molecule against the validated target Sclerostin. OsteoGeneX possesses both near term accelerated clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics.
Company Details
- Employees
- 9
- Address
- 11235 Mastin St, Overland Park,kansas 66210,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.osteogenexinc.com
- Keywords
- INC.
- HQ
- Overland Park, Kansas
Osteogenex, Inc Questions
Osteogenex, Inc's website is https://www.osteogenexinc.com
Osteogenex, Inc's LinkedIn profile is https://www.linkedin.com/company/osteogenex-inc
Osteogenex, Inc has
9 employees.
View email and phone details for 9
employees at Osteogenex, Inc.
Osteogenex, Inc's industry is
Biotechnology Research
Osteogenex, Inc's top competitors are
Jessica Freeman Hr,
Osteogene Tech Corp,
Osteogenics Biomedical, Inc.,
Genex Laboratories Ii, Llc,
Ossifi,
Osteogenix Inc,
Carwin Pharmaceutical Associates,
Genex Global Llc,
Genex Services,
Ossifi Therapeutics.
Osteogenex, Inc's categories are Biotechnology Research
